Uric acid levels predict survival in men with amyotrophic lateral sclerosis.
Ontology highlight
ABSTRACT: Elevated uric acid levels have recently been found to be associated with slower disease progression in Parkinson's disease, Huntington's disease, multiple system atrophy, and mild cognitive impairment. The aim of this study is to determine whether serum uric acid levels predict survival in amyotrophic lateral sclerosis (ALS). A total of 251 people with ALS enrolled in two multicenter clinical trials were included in our analysis. The main outcome measure was survival time, which was calculated as time to death, tracheostomy, or permanent assistive ventilation, with any event considered a survival endpoint. Cox proportional hazards models were used to estimate the hazard ratio (HR) of reaching a survival endpoint according to baseline uric acid levels after adjusting for markers of disease
SUBMITTER: Paganoni S
PROVIDER: S-EPMC4441749 | biostudies-literature | 2012 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA